ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1356	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	general cancer information 0.411851 treatment 0.656267 cancer treatment 0.493001 breast cancer cells 0.486603 primary cancer 0.600191 new cancer treatments 0.408458 Peritoneal Cancer Treatment 0.426103 cancer cells 0.712358 tissue 0.443805 malignant tumor cells 0.423112 body 0.560831 type 0.447878 Cancer Information Service 0.414189 Squamous Neck Cancer 0.400297 PDQ cancer information 0.512966 clinical trial search 0.39505 treatment clinical trials 0.437756 certain changes 0.407705 National Cancer Institute 0.54586 clinical trials 0.823063 normal cells 0.410928 cancer information summary 0.471688 clinical trial 0.588388 new treatment 0.44726	breast cancer prevention 0.400005 primary cancer site 0.517081 cancer tissue 0.403216 patients 0.429603 Cancer Care page 0.397493 PDQ summary 0.435669 treatment clinical trial 0.401935 PDQ Adult Treatment 0.398071 NCI PDQ cancer 0.432436 cancer research process 0.400715 cancer clinical trials 0.44656 tests 0.388491 lymph nodes 0.409196 Unknown Primary Treatment 0.395812 carcinoma 0.39749 primary cancer depend 0.439856 lymph node 0.431668 radiation therapy 0.485838 Treatment Editorial Board 0.413559 cancer information summaries 0.411898 comprehensive cancer information 0.411754 cancer 0.945761 standard treatment 0.426236	CLICK HERE
1363	National Cancer Institute	Html	en	Male Breast Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of male breast cancer.	AI vs 0.370903 mismatch repair mutations 0.369221 Eggemann et al. 0.365773 female breast cancer 0.551031 breast cancer patients. 0.466631 GnRH analogue 0.380989 PDQ cancer information 0.414389 Information About Breast 0.42794 Preoperative Systemic Therapy 0.38272 randomized phase 0.368125 tamoxifen 0.45543 clinical trial 0.36672 Intraductal cancer 0.367134 hormone-releasing hormone 0.373589 Breast Cancer section 0.560693 systemic therapy 0.39727 Postoperative Systemic Therapy 0.381557 AI therapy 0.401771 PDQ Adult Treatment 0.387754 hormonal therapy 0.380314 retrospective analysis 0.368006 gonadotropin-releasing hormone 0.373142 hormone receptor-positive breast 0.492818 breast cancer. 0.41194 German Breast Group 0.488303	et al. 0.433842 Comprehensive Cancer Database 0.381494 nonpolyposis colorectal cancer 0.384245 stage breast cancer 0.454368 Ding et al. 0.368736 male breast cancer 0.671805 Lymph node involvement 0.37157 Early/Localized/Operable Breast Cancer 0.46567 median follow-up 0.370308 ductal cancer 0.367207 Breast Cancer Treatment 0.527076 PDQ Editorial Boards 0.382108 pdq summary 0.467559 adjuvant endocrine therapy 0.440604 early-stage hormone 0.372333 breast cancer 0.962266 adjuvant treatment options 0.385121 AJCC Stage Groupings 0.374688 Zagouri et al. 0.367325 male breast cancers 0.446407 common tumor type. 0.372879 specific treatment modalities 0.365164 analogue versus AI 0.45406 receptor-positive breast cancer 0.49928	CLICK HERE
1428	National Cancer Institute	Html	null	Retinoblastoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of retinoblastoma in children.			CLICK HERE
1828	National Cancer Institute	Html	es	Tratamiento de la leucemia linfoblástica aguda en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda en adultos.	Italy Leukemia Group 0.510748 prognostic factors 0.523487 in adults 0.649162 tirosina cinasa bcr-abl 0.513926 largo plazo 0.507147 leukemia group 0.574628 or fab l3 0.5087 LLA Ph1 0.523666 chronic myeloid leukemia 0.519002 Thiel E 0.520173 TMO autógeno 0.523146 adults with 0.569541 leucemia mielógena 0.512104 donante fraterno 0.513552 lymphocytic leukemia 0.529118 Löffler H 0.510187 LLA recién 0.516678 induction regimen with 0.509327 in adults with 0.545834 patients with 0.533511 complete remission 0.509903 leucemia mielocítica aguda 0.512148 multicenter study 0.514475 adults with standard-risk 0.510496 myeloid leukemia 0.519806	marrow transplantation 0.523773 leucemia aguda 0.509415 leucemia linfoblástica aguda 0.65786 TMO alogénico 0.56508 bone marrow transplantation 0.52273 morfología l3 0.522238 Hoelzer D 0.525554 leukemia with 0.523655 Adult Leukemia Study 0.507091 Northern Italy Leukemia 0.510296 Horowitz MM 0.508541 LLA L3 0.549875 International ALL Trial 0.508909 PDQ Tratamiento 0.509128 Dodge RK 0.508725 Brief-duration high-intensity chemotherapy 0.50796 bone marrow transplant 0.513671 Clin Oncol 0.534506 sistema nervioso central 0.584696 bone marrow 0.527725 with small noncleaved-cell 0.509543 acute lymphoblastic leukemia 0.981898 leukemia with hyper-CVAD 0.507761 lla recidivante quimioterapia 0.519565	CLICK HERE
1869	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando infantil.	Pediatric Oncology 0.427738 Childhood soft tissue 0.412657 Sarcoma Group 0.408529 soft part sarcoma 0.421702 Pediatr Surg Int 0.410488 tumor >5 cm 0.40873 Neonatal soft tissue 0.41137 pediatric nonrhabdomyosarcoma soft 0.423413 soft-tissue sarcoma 0.42357 oncology group study 0.42018 sarcoma necessary after 0.409292 Children's Oncology Group 0.423153 sarcoma results 0.408962 undifferentiated sarcoma 0.409416 5th ed 0.408863 pediatric soft tissue 0.468096 Weiss's Soft Tissue 0.465072 soft tissue sarcoma 0.984779 low-grade fibromyxoid sarcoma 0.417727 Jude Children Research 0.411214 lower extremity sarcomas 0.408827 nonrhabdomyosarcoma soft 0.450499 sarcoma patients 0.409132 End Results 0.409463 Surg Pathol 0.410619	cuello sarcoma 0.408715 Ferrari A 0.410275 Pediatr Blood Cancer 0.449691 Cancer Staging Manual 0.440273 Weiss SW 0.438749 Genes Chromosomes Cancer 0.409368 Translocation-related sarcomas 0.408627 Surg Oncol 0.422483 Adult-type soft tissue 0.411539 Sarcomas embrionarios 0.408595 Pediatr Surg 0.44479 part sarcoma fuses 0.409332 Clin Oncol 0.434253 Children's Research Hospital 0.410798 Goldblum JR 0.438633 sarcomas with surgery 0.409572 soft tissue tumors 0.508399 Pediatric Oncology Group 0.420884 >5 cm 0.415115 retroperitoneo sarcoma 0.408795 round cell tumor 0.41657 Oncology Group 0.440064 localized soft-tissue sarcomas 0.40921 AJCC Cancer Staging 0.461396	CLICK HERE
2066	National Cancer Institute	Html	es	Los cuidados al final de la vida de personas con cáncer	Hoja informativa que responde algunas de las preguntas que tienen muchos pacientes, sus familiares y quienes cuidan de ellos acerca del final de la vida.	desechos quizás 0.586339 pequeñas porciones 0.540804 alcance objetos 0.559532 suficientes glóbulos 0.562578 causa hinchazón 0.558057 dosis correctos 0.546349 médicos cuánto tiempo 0.63336 suficiente oxígeno 0.652738 cuánto tiempo 0.903324 suficiente tejido 0.550065 paciente experimenta síntomas 0.986626 paciente quizás 0.789052 considerable agitación 0.540843 quizás querrán 0.579319	menor flujo 0.542617 presente somnolencia 0.544492 reducida capacidad 0.540414 persona enferma causa 0.731054 malos días 0.539357 mejores cuidadores 0.583437 Mayor debilidad 0.544974 falsas esperanzas 0.572246 siguientes situaciones 0.566454 cuerpo boca 0.542456 familia esté lista 0.658292 paciente presente incontinencia 0.756496 persona quizás 0.668635	CLICK HERE
2068	National Cancer Institute	Html	es	Marcadores de tumores	Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer.	Bast RC Jr 0.727949 cancer screening 0.603977 Gray RJ 0.462067 randomized european study 0.51305 Asociación Estadounidense 0.468124 estudio plco 0.461327 Bigbee W 0.467579 amplia gama 0.464843 afecciones benignas 0.671952 Herberman RB 0.469893 Prevention Research 0.463207 BC Decker Inc 0.509079 Clinical Laboratory Improvement 0.519898 Cancer Screening Randomized 0.544857 Controlled Trial 0.467216 riesgo intermedio 0.462476 Clinical Practice 0.47196 ecografía transvaginal 0.471751 Makower DF 0.466396 estudio tailorx 0.460805 ¿Cuáles marcadores 0.637902 21-gene expression assay 0.514014	Hugosson J 0.463892 Instituto Nacional 0.461324 screening trial specimens 0.541412 Oncología Clínica 0.463202 tumor markers 0.619108 Andriole G 0.463781 Mortality results from 0.526447 Quality Requirements 0.470424 Kufe DW 0.468535 Black A 0.461077 6th ed 0.467056 Oncotype DX® 0.469566 situaciones benignas 0.492829 PubMed Abstract 0.928354 tratamientos resultantes 0.466203 Buys SS 0.460749 Bioquímica Clínica 0.461341 Pollock RE 0.46616 New England Journal 0.930005 Roobol MJ 0.466517 Sparano JA 0.466154 hoja informativa estadificación 0.539118	CLICK HERE
3429	National Cancer Institute	Html	es	Agua fluorada	Hoja informativa que examina los estudios realizados sobre la posible conexión entre el agua fluorada y el cáncer.	Villanacci JF 0.447057 Feltbower RG 0.446597 fluoruro ingerido 0.954566 Mortality Weekly Report 0.483586 vasta cantidad 0.449716 carcinogenicity studies with 0.478781 bajas. Muchos estudios 0.468962 Water Fluoridation Statistics 0.487645 Toxicology Program rodent 0.480514 Napier TS 0.445775 Ewing sarcoma diagnosed 0.483942 Great Britain 0.443018 Disease Control 0.536557 public drinking water 0.505168 National Academy 0.558901 Instituto Nacional 0.520062 agua ayuda 0.629089 Environmental Health 0.58081 Related Programs 0.449277 Estados Unidos 0.666074 Kim FM 0.441491 resultados contradictorios 0.444365 Ingested Fluoride 0.54922 PubMed Abstract 0.93552	among 0-49-year-olds 0.445423 Williams PL 0.44275 salud pública 0.65032 Ad Hoc Subcommittee 0.477798 International Journal 0.533052 Blakey K 0.445319 Dental Research 0.46834 Parslow RC 0.444263 Health Effects 0.572713 Grand Rapids 0.447598 Hejtmancik MR 0.446466 Environmental Health Sciences 0.528481 Hayes C 0.441487 Toft JD 0.447997 drinking water 0.564502 public health 0.755217 National Institute 0.45889 Coordinate Environmental Health 0.506784 prevent dental caries 0.542747 Retrieved August 0.565765 Salud Ambiental 0.441563 National Research Council 0.675505 siglo xx 0.446805 Public Health Service 0.715782	CLICK HERE
3582	National Cancer Institute	Html	en	Frederick National Laboratory for Cancer Research	The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS.	Frederick National Lab 0.679634 Development Center—one 0.586036 Federally Funded Research 0.723777 FNLCR 0.617129 biomarker identification 0.53533 animal sciences 0.53568 national resource 0.541398 government agencies 0.530109 human clinical trials 0.61809 preclinical assay development 0.712354 oncology-focused computational science 0.628628 cancer research laboratories 0.757218 early development 0.553877 research reagents 0.571396 NCI 0.666268 genetically engineered mouse 0.603734 preclinical research 0.638044 nonprofit research organizations 0.690454 broad charter 0.538883 Leidos Biomedical Research 0.735212 United States 0.647036 Nanotechnology Characterization Laboratory 0.625355 RAS family 0.527528 clinical practice 0.533965	NCI investigators 0.632716 significant cancer research 0.722685 translational genomics 0.544933 cancer research 0.952491 private sector business 0.653242 new drug development 0.647375 government sponsors 0.545164 biomedical research community 0.670235 development needs 0.584975 cancer researchers 0.562687 clinical operations 0.542191 Frederick National Laboratory 0.684108 government infrastructure 0.535486 technical staff 0.530406 preclinical model development 0.704349 private sector resources 0.635668 FNLCR programs 0.564698 National lab staff 0.628876 biomedical computing 0.548325 new cancer therapies 0.637914 frozen tumor samples 0.605424 nanotechnology applications 0.53469 cancer research enterprise 0.705608 basic research 0.59861	CLICK HERE
3604	National Cancer Institute	Html	null	Advancing Precision Medicine in Oncology	Multiyear funding for the Precision Medicine Initiative® (PMI) will help accelerate progress toward the promising new era of precision medicine in oncology.			CLICK HERE